Literature DB >> 11574990

Shrinkage of melanoma metastases following high dose intravenous immunoglobulin treatment.

Y Shoenfeld1, Y Levy, P Fishman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11574990

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  8 in total

Review 1.  Uncovering the hidden potential of intravenous immunoglobulin as an anticancer therapy.

Authors:  Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 2.  Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation.

Authors:  R Schwartz-Albiez; R C Monteiro; M Rodriguez; C J Binder; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

3.  The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value.

Authors:  Beatrix Kotlan; Gabriella Liszkay; Miri Blank; Orsolya Csuka; Timea Balatoni; Laszlo Toth; Klara Eles; Szabolcs Horvath; Gyorgy Naszados; Judit Olasz; Balazs Banky; Jozsef Toth; Maria Godeny; Francesco M Marincola; Miklos Kasler; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

4.  Intravenous Immunoglobulin to Suppress Progression in a Patient With Advanced Breast Cancer.

Authors:  Kai-Liang Lin; Ta-Chung Chao; Ming-Han Chen
Journal:  J Breast Cancer       Date:  2022-02-17       Impact factor: 2.922

5.  Intravenous immune globulin suppresses angiogenesis in mice and humans.

Authors:  Reo Yasuma; Valeria Cicatiello; Takeshi Mizutani; Laura Tudisco; Younghee Kim; Valeria Tarallo; Sasha Bogdanovich; Yoshio Hirano; Nagaraj Kerur; Shengjian Li; Tetsuhiro Yasuma; Benjamin J Fowler; Charles B Wright; Ivana Apicella; Adelaide Greco; Arturo Brunetti; Balamurali K Ambati; Sevim Barbasso Helmers; Ingrid E Lundberg; Ondrej Viklicky; Jeanette Hw Leusen; J Sjef Verbeek; Bradley D Gelfand; Ana Bastos-Carvalho; Sandro De Falco; Jayakrishna Ambati
Journal:  Signal Transduct Target Ther       Date:  2016-01-28

6.  Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors.

Authors:  Richard J Jones; Ram K Singh; Fazal Shirazi; Jie Wan; Hua Wang; Xiaobin Wang; Min Jin Ha; Muhamed Baljevic; Isere Kuiatse; Richard E Davis; Robert Z Orlowski
Journal:  Front Immunol       Date:  2020-08-13       Impact factor: 7.561

7.  Binding Performance of Human Intravenous Immunoglobulin and 20(S)-7-Ethylcamptothecin.

Authors:  Yong-Chun Liu; Ying-Ying Li; Xiao-Jun Yao; Hui-Li Qi; Xiao-Xia Wei; Jian-Ning Liu
Journal:  Molecules       Date:  2018-09-18       Impact factor: 4.411

8.  Nonspecific immunoglobulin G is effective in preventing and treating cancer in mice.

Authors:  Qian Xu; Zaiping Zhang; Zhiming Chen; Biying Zhang; Chanyuan Zhao; Yimin Zhang; Conghui Zhao; Xiaodong Deng; Yao Zhou; Yanyun Wu; Jiang Gu
Journal:  Cancer Manag Res       Date:  2019-03-07       Impact factor: 3.989
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.